Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care
This prospective study evaluates a clinically available Alzheimer disease blood test in primary and secondary care using predefined biomarker cutoff values.
Related Articles
Thursday, December 19, 2024 – KFF Health News
Bill of the month, Obamacare enrollment, Medicaid work rules, medication abortion access, bird flu, the opioid crisis, guns, and more.
Belgium to become first EU country to ban disposable vape sales
Belgium will in January become the first European Union country to ban sales of disposable vapes because of concerns about their use among children and…
FDA confirms tirzepatide shortage is over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to…
Vertex’s painkiller results match placebo in study, shares tumble
Vertex Pharmaceuticals said on Thursday its experimental non-opioid drug met the main goal of a mid-stage study but showed little difference versus a placebo in…
Buccal fat removal: What to know about cheek reduction surgery and nonsurgical ways to lose facial fat – Harvard Health
Learn about buccal fat removal surgery and explore non-surgical alternatives for reducing facial fat….
DJI evades US ban but has one year to prove its products aren’t a national security threat
The NDAA (National Defense Authorization Act) spending bill has just been release and it grants DJI a year’s grace before it’s potentially banned in the…
MCP 60 Seconds With Stanislav Henkin, MD, on Post-Pulmonary Embolism Syndrome
View Full-Length Video at: https://youtu.be/ggAcRxKZeywRelated Article Available at: https://mayocl.in/3BN0IMP
Revolutionizing Location Intelligence: TRC’s Innovative Approach to Climate Adaptation and Supply Chain Optimization – What’s Up with Tech?
Discover the cutting-edge world of location intelligence with Todd from TRC, a leader in engineering and energy transition. What happens when an insurance industry expert…
FDA confirms tirzepatide shortage is over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to…
US FDA says Lilly’s weight-loss drug shortage resolved
The U.S. Food and Drug Administration said on Thursday that Eli Lilly’s weight-loss drug shortage has been resolved, following a re-evaluation of the drug’s supply…